伴侣动物抗菌素耐药性传播的公共卫生风险
本文综述伴侣动物抗菌素使用与耐药菌传播的公共卫生风险。伴侣动物与人类密切接触可促进耐药菌种间传播,主要危害包括MRSA、MRSP、VRE、ESBL或产碳青霉烯酶肠杆菌及革兰阴性菌。综述建议在伴侣动物兽药上市许可中引入风险评估工具。
要点
- 伴侣动物与人类密切接触促进耐药菌种间传播。
- 关注MRSA、MRSP、VRE、ESBL/碳青霉烯酶肠杆菌等危害。
- 建议兽药上市许可申请中应用风险评估工具。
核心结论
- 伴侣动物抗菌素耐药性可直接或间接对人类健康造成不良影响,需在兽药审批中引入风险评估。
研究设计与样本
- 综述总结伴侣动物抗菌素使用指征、耐药菌、定植风险因素及耐药性种间传播的现有知识。
主要发现
- 伴侣动物与人类密切接触为耐药菌种间传播创造机会。
- 主要微生物危害包括MRSA、甲氧西林耐药假中间葡萄球菌、VRE、ESBL或产碳青霉烯酶肠杆菌及革兰阴性菌。
- 当前该领域知识有限,批准新兽用抗菌素时未进行风险评估。
临床怎么用
- 在伴侣动物兽药上市许可申请中可应用风险评估工具,以批准公共卫生风险可接受的新兽用抗菌素。
局限性
- 当前关于伴侣动物耐药性传播的知识有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Antimicrobials are important tools for the therapy of infectious bacterial diseases in companion animals. Loss of efficacy of antimicrobial substances can seriously compromise animal health and welfare. A need for the development of new antimicrobials for the therapy of multiresistant infections, particularly those caused by Gram-negative bacteria, has been acknowledged in human medicine and a future corresponding need in veterinary medicine is expected. A unique aspect related to antimicrobial resistance and risk of resistance transfer in companion animals is their close contact with humans. This creates opportunities for interspecies transmission of resistant bacteria. Yet, the current knowledge of this field is limited and no risk assessment is performed when approving new veterinary antimicrobials. The objective of this review is to summarize the current knowledge on the use and indications for antimicrobials in companion animals, drug-resistant bacteria of concern among companion animals, risk factors for colonization of companion animals with resistant bacteria and transmission of antimicrobial resistance (bacteria and/or resistance determinants) between animals and humans. The major antimicrobial resistance microbiological hazards originating from companion animals that directly or indirectly may cause adverse health effects in humans are MRSA, methicillin-resistant Staphylococcus pseudintermedius, VRE, ESBL- or carbapenemase-producing Enterobacteriaceae and Gram-negative bacteria. In the face of the previously recognized microbiological hazards, a risk assessment tool could be applied in applications for marketing authorization for medicinal products for companion animals. This would allow the approval of new veterinary medicinal antimicrobials for which risk levels are estimated as acceptable for public health.
引用
- Pomba C, Rantala M, Greko C, et al. Public health risk of antimicrobial resistance transfer from companion animals. J Antimicrob Chemother. 2017. PMID: 27999066. doi:10.1093/jac/dkw481
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。